December 13, 2017 The company is preparing for an IPO next year, after recently raising money at a $160 million company value. View Article
November 21, 2017 Gamida Cell Appoints Julian Adams, Ph.D., Chairman and Chief Executive Officer View Article
August 21, 2017 Gamida Cell Announces First Patient Transplanted in Phase 1/2 Study of CordIn for Severe Aplastic Anemia and Hypoplastic MDS View Article
August 3, 2017 Cell therapy firm in flurry of activity as hope nears for bone marrow patients View Article
June 19, 2017 Novartis backs Gamida Cell’s $40M raise to fund a looming PhIII study, marketing and manufacturing prep View Article
